Mullins, C. Daniel; Thomas, Simu K.; Roffman, David S. - In: Disease Management and Health Outcomes 9 (2001) 2, pp. 69-74
Restrictions on the use of pharmaceuticals (such as those for low molecular weight heparins) are commonly imposed by healthcare organizations to combat rising health care costs. These restrictions can be system-based which are established by imposing specific coverage policies by insurance...
